[Federal Register Volume 62, Number 129 (Monday, July 7, 1997)]
[Notices]
[Pages 36321-36322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-17538]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 1-10207]


Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration (Alaris Medical, Inc., Common Stock, $.01 Par Value)

June 30, 1997.
    Alaris Medical, Inc. (``Company'') has filed an application with 
the Securities and Exchange Commission (``Commission''), pursuant to 
Section 12(d) of the Securities Exchange Act of

[[Page 36322]]

1934 (``Act'') and Rule 12d2-2(d) promulgated thereunder, to withdraw 
the above specified security (``Security'') from listing and 
registration on the American Stock Exchange, Inc. (``Amex'').
    The reasons cited in the application for withdrawing the Security 
from listing and registration include the following:
    According to the Company, the Board of Directors (the 
``Committee'') unanimously approved a resolution on February 27, 1997 
to withdraw the Company's Security from listing on the Amex and, 
instead, to list such Security on the National Association of 
Securities Dealers Automated Quotation National Market System 
(``Nasdaq/NMS''). The Company's Security began trading on Nasdaq/NMS on 
June 10, 1997. In making the decision to withdraw the Security from 
listing on the Amex, the Company has informed the Commission that it 
has considered the direct and indirect costs and expenses associated 
with maintaining dual listings. The Company does not see any particular 
advantage in the dual trading of its Security.
    The Company has complied with the Rules of the Amex by notifying 
the Amex of its intention to withdraw its Common Stock from listing on 
the Exchange by letter dated May 27, 1997. The Amex has informed the 
Company, by letter dated June 3, 1997, that it has no objection to the 
withdrawal of the Security from listing on the Amex.
    Any interested person may, on or before July 22, 1997, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, N.W., Washington, D.C. 20549, facts bearing upon whether 
the application has been made in accordance with the rules of the 
exchange and what terms, if any, should be imposed by the Commission 
for the protection of investors. The Commission, based on the 
information submitted to it, will issue an order granting the 
application after the date mentioned above, unless the Commission 
determines to order a hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.
Jonathan G. Katz,
Secretary.
[FR Doc. 97-17538 Filed 7-3-97; 8:45 am]
BILLING CODE 8010-01-M